| UHC Medicaid Medical & Drug | Spinraza® (Nusinersen) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Subcutaneous Implantable Naltrexone Pellets – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Surgery of the Hip – Community Plan Medical Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Synagis® (Palivizumab) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Tepezza® (Teprotumumab-Trbw) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Testosterone Replacement or Supplementation Therapy – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Tezspire® (Tezepelumab-Ekko) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Tocilizumab – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Tzield® (Teplizumab-Mzwv) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Uplizna® (Inebilizumab-Cdon) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |